Commission Decision, of 13 May 2014, appointing new members and alternates of Pediatric Committee to represent health professionals and patient associations.
Commission Delegated Decision, of 10 March 2014, setting out criteria and conditions that European Reference Networks and healthcare providers wishing to join a European Reference Network must fulfill.
Commission Communication in the framework of the implementation of the Council Directive 93/42/EEC, of 14 June 1993, concerning medical devices (Publication of titles and references of harmonized standards under Union harmonization legislation).
Commission Regulation (EU) 519/2014, of 16 May 2014
Amends Regulation (EC) 401/2006 as regards methods of sampling of large lots, spices and food supplements, performance criteria for T-2, HT-2 toxin and citrinin and screening methods of analysis.
Commission Implementing Regulation (EU) 563/2014, of 23 May 2014
Approves the basic substance chitosan hydrochloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011.
Regulation (EU) 536/2014 of the European Parliament and of the Council, of 16 April 2014
On clinical trials of medicinal products for human use, and repealing Directive 2001/20/EC.
Commission Delegated Regulation (EU) 622/2014, of 14 February 2014
Establishes a derogation from Regulation (EU) No 1290/2013 of the European Parliament and of the Council laying down the rules for participation and dissemination in ‘Horizon 2020 — the Framework Programme for Research and Innovation (2014-2020)’ with regard to the Innovative Medicines Initiative 2 Joint Undertaking.
Commission Regulation (EU) 686/2014, of 20 June 2014
Amends Regulations (EC) No 983/2009 and (EU) No 384/2010 as regards the conditions of use of certain health claims related to the lowering effect of plant sterols and plant stanols on blood LDL-cholesterol.
Commission Implementing Regulation (EU) 699/2014, of 24 June 2014
On the design of the common logo to identify persons offering medicinal products for sale at a distance to the public and the technical, electronic and cryptographic requirements for verification of its authenticity.
Regulation (EU) 658/2014 of the European Parliament and of the Council, of 15 May 2015
On fees payable of the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use.